Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis Francisco E. Vera-BadilloMarc NapoleoneEitan Amir Review 14 June 2014 Pages: 235 - 244
Pneumonitis and pulmonary fibrosis associated with breast cancer treatments Claudia OmariniEirini ThanopoulouStephen R. D. Johnston Review 15 June 2014 Pages: 245 - 258
A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression Jangsoon LeeChandra BartholomeuszNaoto T. Ueno Preclinical study 12 June 2014 Pages: 259 - 272
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth Stefania CatalanoCinzia GiordanoInes Barone Preclinical study 14 June 2014 Pages: 273 - 285
Recurrent read-through fusion transcripts in breast cancer Katherine E. VarleyJason GertzRichard M. Myers Preclinical study Open access 15 June 2014 Pages: 287 - 297
Monitoring patient-centered outcomes through the progression of breast reconstruction: a multicentered prospective longitudinal evaluation Li-Fen ChaoKetan M. PatelMing-Huei Cheng Preclinical study 21 June 2014 Pages: 299 - 308
Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers Tarek Abdel-FatahArvind AroraSrinivasan Madhusudan Preclinical study 28 June 2014 Pages: 309 - 320
Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer Kristi McIntyreJoyce O’ShaughnessyLinda T. Vahdat Clinical Trial Open access 04 April 2014 Pages: 321 - 328
Erratum to: Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer Kristi McIntyreJoyce O’ShaughnessyLinda T. Vahdat Erratum 19 June 2014 Pages: 329 - 329
Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting Laura EvangelistaAnna Rita CervinoGiorgio Saladini Clinical trial 18 June 2014 Pages: 331 - 340
Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04) Jin Hee KimDoo Ho ChoiChang-Ok Suh Clinical trial 18 June 2014 Pages: 341 - 345
Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast C. Fraga-GuedesH. GobbiG. Viale Clinical trial 19 June 2014 Pages: 347 - 354
Differential impact of body mass index on absolute and percent breast density: implications regarding their use as breast cancer risk biomarkers Susann E. SchetterTerryl J. HartmanAndrea Manni Clinical trial 21 June 2014 Pages: 355 - 363
The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy Amany R. KeruakousBetro T. SadekAlphonse G. Taghian Clinical trial 22 June 2014 Pages: 365 - 370
Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided? Eva Maria FallenbergClarisse DromainFlorian Engelken Clinical trial 02 July 2014 Pages: 371 - 381
Dietary fat intake in relation to lethal breast cancer in two large prospective cohort studies Caroline E. BoekeA. Heather EliassenRulla M. Tamimi Epidemiology 04 June 2014 Pages: 383 - 392
Pregnancy during breast cancer: does a mother’s parity status modify an offspring’s mortality risk? Leonardo SimonellaHelena M. VerkooijenMikael Hartman Epidemiology 17 June 2014 Pages: 393 - 399
Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study Jennifer H. JordanSoe Soe ThwinAnn M. Geiger Epidemiology 18 June 2014 Pages: 401 - 409
Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival Shi-Yi WangJessica B. LongJersey Chen Epidemiology 21 June 2014 Pages: 411 - 419
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers Jacek GronwaldAndre RobidouxThe Hereditary Breast Cancer Clinical Study Group Epidemiology 21 June 2014 Pages: 421 - 427
Differential impact of non-insulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus on breast reconstruction outcomes Charles QinElbert VacaJohn Y. S. Kim Epidemiology 25 June 2014 Pages: 429 - 438
Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women Yong CuiSandra L. Deming-HalversonWei Zheng Epidemiology 02 July 2014 Pages: 439 - 446
Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer K. BellN. HodgsonK. Zbuk Brief Report 12 June 2014 Pages: 447 - 450
Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case series Vincent SibaudRachel E. NiecMario E. Lacouture Brief Report 15 June 2014 Pages: 451 - 456
3D volumetric analysis for planning breast reconstructive surgery Michael P. ChaeDavid J. Hunter-SmithWarren Matthew Rozen Brief Report 18 June 2014 Pages: 457 - 460